TY  - GEN
AU  - Lamanna,Nicole
AU  - Jurcic,Joseph G
AU  - Noy,Ariela
AU  - Maslak,Peter
AU  - Gencarelli,Alison N
AU  - Panageas,Katherine S
AU  - Heaney,Mark L
AU  - Brentjens,Renier J
AU  - Golde,David W
AU  - Scheinberg,David A
AU  - Zelenetz,Andrew D
AU  - Weiss,Mark A
TI  - Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses
SN  - 1527-7755
PY  - 2009///0219
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Agents, Alkylating
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Cyclophosphamide
KW  - Drug Administration Schedule
KW  - Female
KW  - Flow Cytometry
KW  - Follow-Up Studies
KW  - Humans
KW  - Leukemia, Lymphocytic, Chronic, B-Cell
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Polymerase Chain Reaction
KW  - Remission Induction
KW  - Rituximab
KW  - Vidarabine
N1  - Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2008.16.4459
ER  -